Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Healthtrust
Mallinckrodt
Citi
Medtronic
Fuji
Merck
Dow
Argus Health

Generated: June 22, 2018

DrugPatentWatch Database Preview

ATHROMBIN-K Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Athrombin-k, and what generic alternatives are available?

Athrombin-k is a drug marketed by Pharm Res Assoc and is included in one NDA.

The generic ingredient in ATHROMBIN-K is warfarin potassium. There are twenty-two drug master file entries for this compound. Additional details are available on the warfarin potassium profile page.
Summary for ATHROMBIN-K
Drug patent expirations by year for ATHROMBIN-K
Synonyms for ATHROMBIN-K
2610-86-8
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, potassium salt
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, potassium salt (1:1)
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin potassium salt
Antrombin K
Athrombin-K (TN)
C19H15O4.K
CAS-2610-86-8
CHEMBL1200772
COUMARIN, 3-(alpha-ACETONYLBENZYL)-4-HYDROXY-, POTASSIUM SALT
D01280
DSSTox_CID_22324
DSSTox_GSID_42324
DSSTox_RID_79995
DTXSID5042324
LS-55085
NCGC00094810-04
Potassium warfarin
SCHEMBL36363
Tox21_111637
Tox21_111637_1
Warfarin K
Warfarin potassium
Warfarin potassium (JP17)
Warfarin potassium [JAN]
Warfarin potassium [USP:JAN]
Warfarin-potassium
Warfarin-potassium [ISO]
WSHYKIAQCMIPTB-UHFFFAOYSA-M

US Patents and Regulatory Information for ATHROMBIN-K

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Baxter
Covington
Farmers Insurance
McKesson
Cerilliant
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.